[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369878-105":59,"doc-detail-369878-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","proteomic-analysis-uncovers-biological-diversity-in-molecularly-defined-endometrial-carcinomas","Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomas","","Endometrial cancer generally has favorable outcomes, but a subset of patients experience poor prognosis and may require refinement of current classification systems. Molecular classification divides patients into POLEmut, MMRd, p53abn, and NSMP subtypes with distinct risk profiles. Proteomic profiling was used to identify additional prognostic or predictive information across and within these subtypes. Global proteomes from formalin-fixed paraffin-embedded samples covering 184 endometrial cancers were analyzed, including replicate tumor samples and matched biopsy and hysterectomy specimens, yielding four consensus clusters linked to prognosis. Protein expression features were associated with common mutations, molecular subtype, and clinical outcomes.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteomic-analysis-uncovers-biological-diversity-in-molecularly-defined-endometrial-carcinomas/369878/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteomic-analysis-uncovers-biological-diversity-in-molecularly-defined-endometrial-carcinomas/369878.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"How does molecular classification stratify endometrial cancer in this study?","Question",{"text":112,"@type":113},"Patients are categorized into four prognostic subtypes: POLEmut, MMRd, p53abn, and NSMP. POLEmut has the best prognosis, while p53abn has the worst prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What samples and methods were used for proteomic analysis?",{"text":117,"@type":113},"The study performed global proteome profiling on formalin-fixed, paraffin-embedded specimens with clinicopathologic and outcome data. Proteomes were analyzed across four molecular subtypes, including replicate samples and both biopsy and final hysterectomy specimens.",{"name":119,"@type":110,"acceptedAnswer":120},"What did consensus clustering reveal, and how was it interpreted?",{"text":121,"@type":113},"Consensus clustering identified four clusters with different prognoses. The clusters were named based on enriched protein functional characteristics: Adhesion, Immune, Proliferation, and Metabolic.",{"name":123,"@type":110,"acceptedAnswer":124},"What kinds of associations were tested using protein expression features?",{"text":125,"@type":113},"Protein expression features were linked to common mutations, molecular subtype, and clinical outcomes, demonstrating biological diversity both between and within molecular subtypes.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},369878,1790420542,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Neoplasia 69 (2025) 101229  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Original Research\u003Cbr>Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomas\u003Cbr>Dawn R. Cochrane a,b,1,* , Gian Luca Negri c,1 , Jutta Huvila d , Forouh Kalantari e, David A. Farnell f, Nissreen Mohammad f, Emily Thompson f, Winnie Yang a, Amy Lum a , Sandra E. Spencer c, Ryan Riley c, Amy Jamieson b , Samuel Leung g, Derek Chiu g, Christine Chow g , Jamie L.P. Lim a, Martin K¨obel h, Stefan Kommossi, Friedrich Kommoss j, Blake Gilks e,f, Lien Hoang e,f, David G. Huntsman a,b,e,g,h, Gregg B. Morink,c ,\u003Cbr>Jessica N. McAlpine b \u003Cbr>a Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada b Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, BC, Canada c Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, BC, Canada d University of Turku, Turku University Hospital, Turku, Finland\u003Cbr>e Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada f Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, BC, Canada\u003Cbr>g Molecular and Advanced Pathology Core, University of British Columbia, Vancouver, BC, Canada h Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada\u003Cbr>i Department of Obstetrics and Gynecology, University of Tübingen, Germany\u003Cbr>j Institute of Pathology, Medizin Campus Bodensee, Friedrichshafen, Germany k Department of Molecular Genetics, University of British Columbia, Vancouver, BC, Canada |  |  | |\n| --- | --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Endometrial carcinoma Molecular subtype Proteomics |  | While endometrial cancer has an overall favorable prognosis, some patients have poor outcomes and may benefit from further refinements of the current classification systems. Molecular classification stratifies endometrial cancer patients into four prognostic subtypes: POLEmut, MMRd (mismatch repair deficient), p53abn, and NSMP (no specific molecular profile), where patients with POLEmut have the best prognosis and p53abn has the worst prognosis. We used proteomic profiling to assess if additional prognostic or predictive information could be identified across or within molecular subtypes. Global proteome profiling of formalin fixed, paraffin embedded samples, that had clinicopathologic and outcome data, was performed on 184 endometrial cancers encompassing all four molecular subtypes, including replicate samples of the same tumor, and both biopsy and final hysterectomy specimens. To ensure representation of each subtype, we profiled an approximately equal distribution in the 148 unique tumors; 34 (23%) POLEmut, 40 (27%) MMRd, 35 (24%) p53abn and 39 (26%) NSMP, rather than the population-based distributions. There was high reproducibility in the proteomic profiles of intra-tumor replicate samples, and between matched biopsy and hysterectomy tumor samples. Consensus clustering identified four clusters with different prognosis, named ‘Adhesion’,‘Immune’,‘Proliferation’, and ‘Metabolic’ based on the functional characteristics of the enriched proteins. We associated protein expression features with common mutations, molecular subtype, and outcomes. These results demonstrate the biologic diversity within endometrial cancers, both between and within molecular subtypes, and provide candidate features for functional and clinical investigation. |  |\n\n* Corresponding author at: Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.  \nE-mail address: [dcochrane@bccrc.ca](dcochrane@bccrc.ca) (D.R. Cochrane).  \n1 These authors contributed equally to this work.  \n[https://doi.org/10.1016/j.neo.2025.101229](https://doi.or","cbCaiqwDtGSh5aEt","https://ap.wps.com/l/cbCaiqwDtGSh5aEt","pdf",7829417,15,"English","# Abstract\n## Molecular classification and rationale\n## Proteomic profiling approach\n## Clustering and associations with outcomes\n## Key findings and implications","[{\"question\":\"How does molecular classification stratify endometrial cancer in this study?\",\"answer\":\"Patients are categorized into four prognostic subtypes: POLEmut, MMRd, p53abn, and NSMP. POLEmut has the best prognosis, while p53abn has the worst prognosis.\"},{\"question\":\"What samples and methods were used for proteomic analysis?\",\"answer\":\"The study performed global proteome profiling on formalin-fixed, paraffin-embedded specimens with clinicopathologic and outcome data. Proteomes were analyzed across four molecular subtypes, including replicate samples and both biopsy and final hysterectomy specimens.\"},{\"question\":\"What did consensus clustering reveal, and how was it interpreted?\",\"answer\":\"Consensus clustering identified four clusters with different prognoses. The clusters were named based on enriched protein functional characteristics: Adhesion, Immune, Proliferation, and Metabolic.\"},{\"question\":\"What kinds of associations were tested using protein expression features?\",\"answer\":\"Protein expression features were linked to common mutations, molecular subtype, and clinical outcomes, demonstrating biological diversity both between and within molecular subtypes.\"}]","Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomas | PDF",1790185036,38,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07f0b840f07e137000baf811ff32bb86.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a794e5d9e3c7ed8327671f37c465ebff.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/632832767a65f0e7f9eb36c887debee9.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e96808ce0a696f2ddf6a40a410f3e78.webp",980,1306]